Natural history and management of hepatitis C: does sex play a role? (Q42208880)

18 October 2017

Natural history and management of hepatitis C: does sex play a role? (English)

1 reference

18 October 2017

1 reference

2

Jürgen K Rockstroh

1 reference

18 October 2017

3

Maria Buti

1 reference

18 October 2017

Rachel Baden

1

1 reference

PubMed ID

24966194

18 October 2017

language of work or name

English

0 references

publication date

1 July 2014

1 reference

Journal of Infectious Diseases

18 October 2017

1 reference

18 October 2017

209 Suppl 3

1 reference

18 October 2017

S81-5

1 reference

Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention

18 October 2017

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany--a 25-year multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Higher clearance of hepatitis C virus infection in females compared with males

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Impact of oestrogens on the progression of liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Impact of alcohol on the histological and clinical progression of hepatitis C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Gender and alcohol consumption: patterns from the multinational GENACIS project

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Boceprevir for untreated chronic HCV genotype 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Telaprevir for previously untreated chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Sofosbuvir for previously untreated chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

Baseline Characteristics and Mortality Among People in Care for Chronic Viral Hepatitis: The Chronic Hepatitis Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU057

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIU057

1 reference

18 October 2017

1 reference

PubMed ID

24966194